新生儿黄疸采用白蛋白联合蓝光照射治疗的疗效分析

The treatment of neonatal jaundice with white protein combined with blue light irradiation therapy was analyzed

目的探究在新生儿黄疸的临床治疗中白蛋白联合蓝光照射进行治疗的效果。方法 2016年1月-2016年9月,我院新生儿科接受治疗的新生儿黄疸患儿94例,结合其接受治疗的先后顺序进行分组,其中单号设定为对照组,双号设定为观察组,对照组患儿应用蓝光照射进行病情缓解,观察组患儿则在蓝光照射的基础上结合白蛋白进行治疗,对比两组患儿的临床治疗效果。结果观察组黄疸新生儿应用联合治疗的总有效率明显高于对照组,差异有统计学意义（P〈0.05）,同时观察组新生儿治疗期间的不良反应发生率明显低于对照组,差异有统计学意义（P〈0.05）。结论在黄疸新生儿患儿的临床治疗中应用白蛋白联合蓝光照射进行治疗能够有效改善患儿的临床治疗效果,同时降低不良反应发生率,值得在临床治疗中推广应用。

Objective To explore the therapeutic effect of albumin combined with blue light in the clinical treatment of neonatal jaundice. Methods January 2016-September 2016, our hospital of treatment of 94 cases of neonatal jaundice, combined with the order of the treatment group, the number is set as the control group, set the double number as observation group and control group with blue light was used to remission, while the observation group with blue light treatment combined with albumin, on the basis of comparing the clinical therapeutic effects of two groups of children. Results The observation group of jaundice infants application and total effective rate of combined treatment was obviously higher than that of control group, the difference was statistically significant(P<0.05), and neonatal treatment the incidence of adverse reactions during the observation group was obviously lower than the control group, the difference was statistically significant(P<0.05). Conclusion Applied in the clinical treatment of children with jaundice infants albumin joint blue light treatment can effectively improve the patient's clinical curative effect, at the same time reduce the incidence of adverse reactions, is worthy of popularization and application in the clinical treatment.